Buyside articles from December 2001

Buyside archives from December 2001

Tyson Foods, Inc. (Prudential Securities).(stock profile)(Brief Article)(Statistical Data Included)
December 22, 2001... Company Profile: Tyson Foods, Inc., founded in 1935, with headquarters in Springdale, Ark., is the world's largest processor and marketer of beef, chicken and pork. Tyson Foods produces a wide variety of brand name, processed food products...

Biomira Inc. (Research Report).(Brief Article)(Statistical Data Included)
December 22, 2001... BIOTECHNOLOGY (BIOM: NASDAQ) Recommendation: Strong Buy EDWARD NASH (212) 409-2161 Company Description: Biomira Inc. is a product based biotechnology company with a proprietary immunotherapy and organic chemistry platform...

Symantec[TM]. (Analyst Roundtable).(Statistical Data Included)
December 22, 2001... Symantec Corporation (SYMC) provides Internet security and computer administration software to the consumer, enterprise and service provider markets. Melissa Eisenstat CIBC World Markets (212) 667-8130 We rate Symantec a...

Pharma. (Analyst Roundtable).(Statistical Data Included)
December 22, 2001... MGI PHARMA (MOGN) is an oncology-focused pharmaceutical company that acquires, develops and commercializes proprietary products that address unmet cancer patient needs. MGI is building a balanced product portfolio of proprietary...

Clinical Trials. (Publisher's Letter).
December 22, 2001... For all of you who stood fast and said, "The markets will bounce back -- sooner rather than later," we say, "Bravo!" The markets will remain choppy, no doubt about it. It seems to be the current standard, to the degree that one research...

Wishing You Happiness and Hope Now and In the New Year.
December 22, 2001... Hope is a tattered flag and a dream of time. Hope is a heartspun word, he rainbow, the shadblow in white The evening star inviolable over the coal mines, The shimmer of northern lights across a bitter winter...

The firm, displaced on September 11, buys a Times Square building. (Lehman Relocates).(Brief Article)
December 22, 2001... Lehman Brothers will buy a Times Square office building from Morgan Stanley Dean Witter & Co. to replace office space lost in the September 11 attacks, the companies said Monday. This will allow more than 5,000 Lehman jobs to remain in New York...

3Q01 Shows Merrill On Top In First Call's Readership Rankings. (Must Read).(Brief Article)
December 22, 2001... Thomson Financial announced the results of its quarterly broker readership rankings. Merrill Lynch captured the top position as the most-read brokerage firm worldwide in the third quarter of 2001. The rankings are based on readership statistics...

The Road To Venture Capital Is A Rough Ride. (Entrepreneurs Buckle Up).(Brief Article)
December 22, 2001... Eighty venture capital firma across the U.S. recently participated in the extensive survey conducted by Profit Dynamics. Dee Power & Brian Hill of Profit Dynamics, authors of the survey, speak out about their findings. A sample of the...

Credit Suisse Initiative Seeks Enhanced Distribution and A Name Change. (A Fund by Any Other Name...).(Brief Article)
December 22, 2001... In a move to provide investors and their advisors broader access to its investment strategies, Credit Suisse Asset Management (CSAM Americas) announced plans to enhance its mutual fund distribution strategy and reposition its products in the...

New Study Demonstrates Value of Professional Market Timing. (Timing is Everything).(Brief Article)
December 22, 2001... The study, conducted by Prof. Don Chance, Department of Finance at Virginia Tech, and Prof. Michael Hemler, Department of Finance and Business Economics at the University of Notre Dame, found evidence of significant ability of the market...

Tracks and Treks of Fund Managers and Analysts. (Buyside on the Buy Side).
December 22, 2001... Neuberger Berman announced plans to acquire the assets of Oscar Capital Management. Oscar Capital will be known as Neuberger Berman. There are no planned staffing changes and it is not yet known whether any of the fund names will change....

Sell Side Kudos. (Insights).(Brief Article)
December 22, 2001... Goldman Sachs has named Kimberly Ritrievi and David Tenney as co-directors of investment research for the U.S. They will be based in New York. Ritrievi joined the firm in 1997 and has served as a research analyst covering specialty chemical...

For Strong Buys Only.
December 22, 2001... Making the Grade BUYSIDE'S WHO'S-WHO OF STOCKS THAT MADE THE GRADE WITH A RECOMMENDATION UPGRADE OR INITIATION TO 'STRONG BUY' Meghan Leerskov Advertising COMPANY TICKER ANALYST The Ackerley...

Paradigm Genetics, Inc. (Needham).(Brief Article)(Statistical Data Included)
December 22, 2001... Company Profile: Paradigm Genetics, Inc. is industrializing the process of determining gene function to generate information that can be used to develop products in four major sectors of the global economy: human health, nutrition, crop...

Stormy Weather: Precious Few IPOs Sprint through Market's Hail, but Manage to Stay Relatively Dry. (IPOs).(three new initial public offerings)(Brief Article)
December 22, 2001... Only three IPOs premiered in August, making it to market not long before September 11. Despite the temporary setback, the market came back to life, and its newest IPOs impressed market watchers by staying afloat as they weathered the storm. ...

A Safer Bet: The Price of Risk, New Derivatives and Complete Markets. (Tech Strategies).(Brief Article)
December 22, 2001... The capital markets provide a satisfactory solution for the transfer of risks related to clearly defined underlying securities or instruments. However, there is substantial anecdotal and academic evidence that the potential transaction volume...

The New Pru: To Solidify the Rock's Star Product, its Research, Prudential cuts the Cord between IT and Investment Banking. Buyside takes a look at Baby's First Steps. (Prudential Financial).
December 22, 2001... When John Strangfeld took over as chief executive officer of Prudential Securities, he promised to shake things up. The rafters are still vibrating. Touting independent, uncompromised investment research, his first order of business was to cut...

ICOS Corporation. (Prudential Securities).(stock profile)(Brief Article)(Statistical Data Included)
December 22, 2001... Company Profile: ICOS Corporation is a biotechnology company based in Bothell, Wash. Building on a scientific focus on inflammation the company has a broad pipeline of products that target a diverse range of conditions. ICOS' lead product...

St. Jude Medical, Inc. (Prudential Securities).(stock profile)(Brief Article)(Statistical Data Included)
December 22, 2001... Company Profile: St. Jude Medical, Inc. based in St. Paul, Minn., develops, manufactures, and markets medical devices primarily for cardiac care. Products include heart valves, pacemakers, implantable cardioverter defibrillators (ICDs),...

Sierra Health Services, Inc. (Prudential Securities).(stock profile)(Brief Article)(Statistical Data Included)
December 22, 2001... Company Profile: Sierra Health Services, Inc., based in Las Vegas, is a diversified health care services company that operates health maintenance organizations, indemnity and workers' compensation insurers, military health programs,...

Corn Products International, Inc. (Prudential Securities).(stock profile)(Brief Article)(Statistical Data Included)
December 22, 2001... Company Profile: Corn Products International, Inc. is one of the world's largest corn refiners, with operations primarily in North America, Latin America, and Asia. The company is the fourth-largest corn refiner in the U.S. and holds...

The Hain Celestial Group, Inc. (Prudential Securities).(stock profile)(Brief Article)(Statistical Data Included)
December 22, 2001... Company Profile: The Hain Celestial Group, Inc. is based in Melville, NY. Although Hain Celestial Group is not yet well known to the average supermarket shopper, its portfolio of "better for you" brands is well known to health food store...

Serena Software, Inc. (Prudential Securities).(Brief Article)
December 22, 2001... Company Profile: SERENA Software is headquartered in Burlingame, CA, and founded in 1980. The company is a leading provider of automated software change management (SCM) tools. With multi-platform solutions spanning the mainframe to UNIX...

Medical Wonders: Top Healthcare Fund Managers Master The Dual Discipline of Medicine and Finance, Putting Life Sciences under the Microscope and Finding Top Performance. (Top Healthcare Fund Managers).
December 22, 2001... As an institutional investor, it's crucial to take your cues from the best of the best. That is the drive behind the following conversations with managers of top healthcare funds. They face the everyday rigor of pairing the potential of life...

A Prescription for Growth: Priming Pipelines and Dealing with Products going Off-Patent, The Drug Industry should Help Prop Up Investors beyond 2001. (Biotech & Pharmaceuticals).
December 22, 2001... While semiconductor manufacturers struggle to unload their excessive inventories, biotechnology researchers have no shortage of diseases and other ailments for which to supply treatment products. While telecommunications companies search for...

Intel Inside[R].
December 22, 2001... About Intel [right arrow] Today, Intel supplies the computing and communications industries with chips, boards and systems building blocks that are the "ingredients" of computers, servers, and networking and communications products. These...

Refractive Surgery: Demand Growing, Prices Stabilizing. (Investments In Sight).(Brief Article)
December 22, 2001... U.S. refractive procedures are projected to grow 21% in 2001 and at a slower rate for the next several years. Healthy growth during the last year came despite the U.S. economic slowdown, lower employment levels and declining consumer...

Cataract Surgery Boom Will Continue. (Investments In Sight).(Brief Article)
December 22, 2001... Cataract extraction with intraocular lens (IOL) implantation is the most common surgical procedure performed in the U.S. and most other wealthy nations. It is the main source of income for most ophthalmic surgeons and generates the most device...

Contact Lenses: Focusing on Younger Wearers with Higher-Margin Products. (Investments In Sight).(Brief Article)
December 22, 2001... Unlike much of the rest of the health care industry, which expects to benefit from the "graying of America," contact lens manufacturers are eyeing a much younger demographic: 15- to 19-year-olds, the prime market for initial users of contact...

Aging Population Spurs AMD and Glaucoma Research. (Investments In Sight).(age-related macular degeneration)(Brief Article)
December 22, 2001... Glaucoma affects 67 million people worldwide and 1% to 2% of Americans, especially after age 60. It is the second leading cause of blindness in Caucasians and the leading cause in people of African descent. There is no cure for most forms, but...

Low Vision: A Growing, Untapped Market. (Investments In Sight).(Brief Article)
December 22, 2001... Low vision device companies are involved in a huge market that includes major portions of the populations suffering from diabetic retinopathy, glaucoma, retinitis pigmenrosa, macular degeneration, and, to a lesser extent, cataracts. Most...

The Cooper Companies: Specialty Contact Lenses Fuel Growth. (Investments In Sight).(Brief Article)
December 22, 2001... With a record of consistent yearly growth, The Cooper Companies' CooperVision (CVI) division is forging ahead with a pipeline of innovative new contact lenses. Headlining this surge in product development are the company's latest entries in the...

VISX: Targeting the "96% Opportunity" in Laser Vision Correction Market. (Investments In Sight).(Brief Article)
December 22, 2001... Building on its proprietary strength, solid financial performance, and continued commitment to research and development, VISX, Incorporated is moving to expand its leadership in the market for laser vision correction. The growth potential...

IRIDEX: Developing Unique Applications in the Fight Against Sight-Threatening Diseases. (Investments In Sight).(Brief Article)
December 22, 2001... Even in a market characterized by excellent innovation, IRIDEX stands out with sophisticated enhancements to its state-of-the-art technology. IRIDEX is well-known for its solid-state lasers sold to ophthalmologists under the brand name IRIS...

QLT: Building Success Through Profitable Biotechnology. (Investments In Sight).(Brief Article)
December 22, 2001... QLT Inc. earned its reputation as a world leader in photodynamic therapy (PDT), a field of medicine that uses light-activated drugs to combat debilitating diseases, but bolstered its business and reputation when it brought to market visudyne...

ISTA Pharmaceuticals: Developing Non-Surgical Treatments for Underserved, Serious Eye Conditions. (Investments In Sight).(Brief Article)
December 22, 2001... Founded in 1992, ISTA Pharmaceuticals is focused on saving and improving eyesight by developing proprietary, non-surgical products to treat serious diseases and conditions of the eye. ISTA recently announced that it had completed patient...

Santen Pharmaceutical: World Leader That's Expanding its U.S. Position in Applications for Eye Diseases. (Investments In Sight).(Brief Article)
December 22, 2001... Santen is an increasingly visible U.S. marketer of two important new eye care pharmaceuticals and one well-known branded glaucoma medication. The leading ophthalmic pharmaceutical company in Japan since 1890, Santen specializes in...

Betacom Corporation: Targeting the Needs of 135 Million People Worldwide with Vision Impairment. (Investments In Sight).(Brief Article)
December 22, 2001... Betacom Corporation Inc. is a Canadian company positioned for rapid growth in North America and throughout the world. In the second quarter of its fiscal year (ended August 31), Betacom achieved a 117% sales increase, with margins rising from...

Nanogen[R].(Brief Article)
December 22, 2001... NASDAQ: NGEN ... Bridging the Gap Between Research and Clinical Diagnostics Overview Nanogen, Inc. (Nasdaq: NGEN) aims to be the leading provider of electronic microarray technology with the required accuracy, simplicity and...

Insmed Incorporated. (Prudential Securities).(Brief Article)(Statistical Data Included)
December 22, 2001... Company Profile: Insmed Incorporated of Richmond, VA discovers and develops pharmaceutical products for the treatment of metabolic and endocrine diseases associated with insulin resistance. The company is conducting a series of Phase II...

Checking In: Hospitals, HMOs and Managed Care Companies Offer Crucial Care and Quiet Strength.(Statistical Data Included)
December 22, 2001... Scott Estes is a unique kind of analyst these days: He's unabashedly bullish about his sector: healthcare. "There's not many that I don't like," says Estes, a vice president and senior analyst with Deutsche Banc Alex. Brown, who believes...

Gurus of Healthcare: In a Sector Driven by Trends, it's Good to Know the Drivers. (HealthCare Gurus).(Brief Article)
December 22, 2001... The healthcare sector is the classic safe haven for investors. It is relatively immune to the ups and downs of the economy. It stands to benefit from favorable demographics, as people -- both in the U.S. and abroad, get older and live longer....

Friedman, Billings, Ramsey & Co.: Diversa Corporation. (Research Report).(Brief Article)(Statistical Data Included)
December 22, 2001... Company Description Diversa Corporation is a global leader in developing and applying proprietary technologies to discover and evolve novel genes and gene pathways from diverse environmental sources. The company is utilizing its fully...

The Beltway Boys: D.C. based Friedman, Billings Ramsey & Co. is on the Spot for Crucial Drug Research. (Friedman, Billings, Ramsey & Co.).
December 22, 2001... Biocoastal snobs will tell you there are really only two cities in America: New York and Los Angeles. But if you're a healthcare analyst, you'd probably change that to New York and Washington. D.C. As the only investment bank located in...

Product of their Efforts: Adams, Harkness & Hill's Biotech Team focuses on the Pipeline. (Adams, Harkness & Hill).(Brief Article)
December 22, 2001... These are unprecedented times in biotech. Not only are scientific advances coming out as if they were on a high-speed assembly line, the business side is equally as astounding. In September Bristol-Myers Squibb Co. announced it will pay ImClone...

Xoma. (Analyst Roundtable).(Brief Article)(Statistical Data Included)
December 22, 2001... XOMA (XOMA) develops and manufactures innovative biopharmaceuticals for disease targets that include cancer, immunological and inflammatory disorders and infectious diseases. Rick Stover Arnhold & S. Bleichroeder (212)698-3141 ...

Cephalon, Inc.: Adams, Harkness & Hill. (The Emerging Growth Investment Bank).(Brief Article)
December 22, 2001... Company Description: Cephalon, Inc., is an international biopharmaceutical company dedicated to the discovery, development and marketing of innovative products to treat neurological and sleep disorders as well as cancer and pain. The...

Therapeutic Approach: Wachovia Securities' HealthCare Team seeks Opportunities in Mid-Cap and Emerging Growth Companies. (Wachovia Securities).(Statistical Data Included)
December 22, 2001... Consistent with the firm's overall approach, Wachovia's healthcare research team is carving out a niche for itself among mid-cap and emerging growth companies. "Half of the six healthcare analysts have been hired in the past 18 months...

Impax Laboratories, Inc. (Wachovia Securities).(Brief Article)(Statistical Data Included)
December 22, 2001... 52-Wk. Range.: $17-5 Shares Out: (MM) 46.0 Market Cap.:(MM) 412.2 October 30, 2001 Target Price: $18 Float: (MM) 10.7 Avg. Daily Vol.: 282,210 S&P 500: 1,118.43 Div./Yield: $0.00/0.0% LT Debt:(MM) $3.4...

Orthofix International N.V. (Wachovia Securities).(Brief Article)(Statistical Data Included)
December 22, 2001... Price: $34 52-Wk. Rng.: $32-14 Shares Out.:(MM) 14.7 Market Cap.: (MM) 474.8 October 25, 2001 Company Description Orthofix International N.V. develops, manufactures, and sells a variety of orthopedic-related medical...

Biotech Success: Roth Capital Partners' Formula: Small Caps + Deep Knowledge = Value. (Roth Capital Partners).(Statistical Data Included)
December 22, 2001... Biotech has become a tougher gig for analysts and investors during the past year, but there still are areas in the sector poised for growth in the coming months, says Fariba Ghodsian, PhD, managing director and director of healthcare research...

Roth Capital Partners.(issues Nabi earnings projection)(Brief Article)(Statistical Data Included)
December 22, 2001... RATING STRONG BUY Company Description: Nabi, a fully integrated biopharmaceutical company, has a broad product portfolio and significant R&D capabilities focused on the development and commercialization of products that prevent and...

Beefing Up In Biotech: Zigging when others ZAG, Ladenburg Thalmann builds on its BioTech Team. (Ladenburg Thalmann).(Brief Article)
December 22, 2001... Despite Ladenburg Thalmann being a smaller firm, Donald Newman, managing director and director of research, believes biotech is an area in which it can make a mark. This year the 126-year-old firm created a biotech team. "We feel that with a...

Immunomedics, Inc. (Ladenburg Thalmann).(Ladenburg Thalmann issues Immunomedics Inc. financial report, includes company description and investment points)(Brief Article)(Statistical Data Included)
December 22, 2001... Company Description: Immunomedics, Inc. is a biopharmaceutical company with a proprietary pipeline of 'naked' and conjugated monoclonal antibodies for the detection and treatment of cancers. The versatility of Immunomedics' technology is...

Biotech, Craft & Science. (Ladenburg Thalmann).(Edward Nash discusses biotechnology industry investment strategy)(Brief Article)
December 22, 2001... Biotech investing is one-third finance, two-thirds science. Edward Nash employs the best of both with his biotech research, but it's only natural - it's an apt description of how he came to be at Ladenburg Thalmann at all, let alone in...

Vasogen Inc. (Ladenburg Thalmann).(Ladenburg Thalmann issues Vasogen Inc. report, includes financial data, company description, and investment points)(Brief Article)(Statistical Data Included)
December 22, 2001... Company Description: Vasogen Inc. is engaged in the development and commercialization of a therapeutic platform technology designed to treat cardiovascular, autoimmune, and related inflammatory diseases by harnessing the power of the...

The Cooper Companies.(includes financial data and growth strategy)(Brief Article)(Statistical Data Included)
December 22, 2001... The Cooper Companies (COO) is a rapidly growing specialty healthcare company with two business units. CooperVision markets a broad range of contact lenses throughout the world and CooperSurgical markets diagnostic products, surgical instruments...

Verizon Communications Inc.(includes year 2000 revenues and subscriber data)(Brief Article)(Company Profile)(Statistical Data Included)
December 22, 2001... Driven by our belief in the power of networks, the value of customer connections and the magic of a unified brand, Verizon is becoming one of the worlds leading communications companies. With our unparalleled national scale in landline and...

Child's Play. (Editor's Letter).(BuySideCanada September isuue features professional women cover stories)(Brief Article)(Editorial)
December 22, 2001... This past Wednesday, November 7, was National Take Our Kids to Work Day, and we at BuysideCanada feel right in line with that. Our September cover stories, "Top Women of Bay Street" and "Top Women of Wall Street," received high accolades from...

Draxis at a Glance. (Draxis).(DRAXIS Health Inc., includes revenue data and corporate summary)(Brief Article)(Statistical Data Included)
December 22, 2001... Exchanges/Tickers: NASDAQ: DRAX; TSE: DAX Shares Outstanding: 36.6 Million (Float: 30.0 Million) Market Cap: US$75 Million (on TTM Sales of US$39 Million) 52-Week Low/High: US$1.45 -2.36 (as of November 26, 2001) CORPORATE...

Gurus of Healthcare: Top Market Watchers Survey the Landscape. (Healthcare Gurus).(Statistical Data Included)
December 22, 2001... The old adage may be that the only constant is change, but there are few areas in which change occurs with such a profound impact. BuysideCanada taps the key players in healthcare -- the gurus -- to get the inside track on one of the most...

Bill of Health: The Move To Privatized Healthcare Steps Up Its Pace. (Health Care).
December 22, 2001... Canada's socialized system of healthcare has not made it the most fertile sector for healthcare I/Os. While 70% of healthcare in Canada is publicly financed, nearly all of it is privately provided. Almost all hospitals are non-profit private...

Buyside Canada on the Buy Side. (Canada Insights/Conference Calendar).(Brief Article)
December 22, 2001... Clarica Diversico has selected three new portfolio advisers to manage five of its Canadian retail mutual funds with total assets of $2.2 billion. Brinson Canada Co. has been selected to manage the Clarica Premier Growth Fund with assets of...